Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Hypoxia (Auckland, N.Z.)|August 16, 2016
The 2-oxoglutarate analog 3-oxoglutarate decreases normoxic hypoxia-inducible factor-1α in cancer cells, induces cell death, and reduces tumor xenograft growthPeppi Koivunen, Stuart M Fell, Wenyun Lu, et al.Hypoxia (Auckland, N.Z.)|May 24, 2019
Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor modelPoonam Yakkundi, Eleanor Gonsalves, Maria Galou-Lameyer, et al.Hypoxia (Auckland, N.Z.)|June 5, 2018
Effects of human relaxin-2 (serelaxin) on hypoxic pulmonary vasoconstriction during acute hypoxia in a sheep modelRené Schiffner, Marius Nistor, Sabine Juliane Bischoff, et al.Hypoxia (Auckland, N.Z.)|February 28, 2020
Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel DiseaseEdwin F deZoeten, Kayla D Battista, Steven B Colson, et al.Hypoxia (Auckland, N.Z.)|November 2, 2016
Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo-/- miceElizabeth J Campbell, Margreet Cm Vissers, Gabi U DachsHypoxia (Auckland, N.Z.)|November 2, 2016
PHD2: from hypoxia regulation to disease progressionAna M Meneses, Ben WielockxHypoxia (Auckland, N.Z.)|November 2, 2016
Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cellsAndreas David Zimmer, Geoffroy Walbrecq, Ines Kozar, et al.Hypoxia (Auckland, N.Z.)|July 16, 2014
The impact of hypoxia in pancreatic cancer invasion and metastasisAngela Yuen, Begoña DíazHypoxia (Auckland, N.Z.)|September 11, 2014
Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposureLouise Ostergaard, Alain Rudiger, Sven Wellmann, et al.Hypoxia (Auckland, N.Z.)|October 25, 2016
Measuring oxygen levels in Caco-2 culturesNathalie E Zeitouni, Joachim Fandrey, Hassan Y Naim, et al.Pageof 7